gadolinium dtpa has been researched along with Headache Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, MH; Bauchet, L; Capelle, L; Duffau, H; Fontaine, D; Guillevin, R; Guyotat, J; Kujas, M; Laigle-Donadey, F; Mandonnet, E; Mokhtari, K; Pallud, J; Peruzzi, P; Taillandier, L | 1 |
1 other study(ies) available for gadolinium dtpa and Headache Disorders
| Article | Year |
|---|---|
Prognostic significance of imaging contrast enhancement for WHO grade II gliomas.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Contrast Media; Female; Gadolinium DTPA; Glioma; Headache Disorders; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Nervous System Diseases; Prognosis; Seizures; Survival Rate; Young Adult | 2009 |